FDA Employees Were ‘Granting Approval Without Knowing Why,’ Judge Rules In Ranbaxy Case
This article was originally published in The Pink Sheet Daily
Executive Summary
But court finds FDA has authority to correct its mistakes and revoke Ranbaxy’s tentative ANDA approvals